Poster Author Of 6 e-Posters
38 - The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems
Presentation Number
38
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Vieira, Boston, MA, United States of America
- M. Pfeffer, Lebanon, NH, United States of America
- B. Claggett, Boston, MA, United States of America
- J. Connors, Boston, MA, United States of America
- G. Stewart, Boston, MA, United States of America
- M. Givertz, Boston, MA, United States of America
- L. Coakley, Boston, MA, United States of America
- H. Mallidi, Boston, MA, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
82 - Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis
Presentation Number
82
Session Name
SESSION 24 - ORAL: How Far Can We Go? Pushing the Limits in Donor Heart Utilization
Date
Thu, Apr 23, 2020
Time
08:15 AM - 10:00 AM
93 - The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial
Presentation Number
93
Session Name
SESSION 29 - ORAL: Anticoagulation and Bleeding Complications in MCS Patients
Date
Thu, Apr 23, 2020
Time
02:00 PM - 03:45 PM
Authors
- O. Saeed, Bronx, NY, United States of America
- P. Columbo, New York, NY, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
- N. Uriel, Bronx, NY, United States of America
- D. Goldstein, Bronx, NY, United States of America
- J. Cleveland, Colorado Springs, CO, United States of America
- J. Conners, Boston, MA, United States of America
- S. Najjar, Washington, DC, United States of America
- N. Mokadam, Columbus, OH, United States of America
- A. Bansal, New Orleans, LA, United States of America
- D. Crandall, Burlington, MA, United States of America
- P. Sood, Abbott Park, IL, United States of America
- U. Jorde, Bronx, NY, United States of America
262 - Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study
Presentation Number
262
Session Name
SESSION 71 - ORAL: Valve Regurgitation in MCS Patients
Date
Sat, Apr 25, 2020
Time
08:15 AM - 10:00 AM
375 - Implementation of Patient-Centered Shared Decision Making for LVAD Candidates: Year 1 Results of a Multi-Site Study
Presentation Number
375
Session Name
MINI ORAL 03 - MINI ORAL SESSION: Managing LVAD Patients
Date
Wed, Apr 22, 2020
Time
06:15 PM - 07:15 PM
Authors
- J. Blumenthal-Barby, Houston, TX, United States of America
- K. Kostick, Houston, TX, United States of America
- M. Trejo, Houston, TX, United States of America
- A. Bhimaraj, Houston, TX, United States of America
- A. Civitello, Houston, TX, United States of America
- D. Horstmanshof, Oklahoma City, OK, United States of America
- U. Jorde, Bronx, NY, United States of America
- M. Loebe, Miami, FL, United States of America
- M. Mehra, Pittsburgh, PA, United States of America
- V. Thohan, Asheville, NC, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- N. Uriel, Bronx, NY, United States of America
- R. Volk, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Immunosuppression, Therapeutics and Pharmacology
Abstracts
1293 - Efficacy and Safety of LCP-Tacrolimus (Envarsus XR®) Conversion Therapy in Heart Transplantation
Presentation Number
1293
Session Name
POSTER SESSION 3 - POSTER SESSION: Pharmacy and Pharmacology
Date
Fri, Apr 24, 2020
Time
06:00 PM - 07:15 PM